Oral antiplatelet therapy in PCI patients

Samin K. Sharma

doi:10.1002/ccd.22367

Oral antiplatelet therapy in PCI patients

Samin K. Sharma

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

The use of percutaneous coronary intervention (PCI) in the treatment of obstructive coronary artery disease has expanded rapidly in the past decade. Despite the extensive technological advancements in the field, pharmacotherapy has remained a cornerstone in the overall treatment strategy. Oral antiplatelet therapy has become an essential component of therapy with acute coronary syndromes and in PCI by improving clinical outcomes. This article reviews the antiplatelet options for patients undergoing PCI, including aspirin, ADP receptor blockers, and glycoprotein IIb/IIIa inhibitors.

Original language	English
Pages (from-to)	S7-S14
Journal	Catheterization and Cardiovascular Interventions
Volume	75
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1002/ccd.22367
State	Published - 2010

Keywords

Acute coronary syndrome (ACS)
Coagulation (COAG)
Percutaneous coronary intervention (PCI)
Thrombosis (THRM)

Access to Document

10.1002/ccd.22367

Cite this

@article{fdbe32c928bc4793860b82d9c7e44993,

title = "Oral antiplatelet therapy in PCI patients",

abstract = "The use of percutaneous coronary intervention (PCI) in the treatment of obstructive coronary artery disease has expanded rapidly in the past decade. Despite the extensive technological advancements in the field, pharmacotherapy has remained a cornerstone in the overall treatment strategy. Oral antiplatelet therapy has become an essential component of therapy with acute coronary syndromes and in PCI by improving clinical outcomes. This article reviews the antiplatelet options for patients undergoing PCI, including aspirin, ADP receptor blockers, and glycoprotein IIb/IIIa inhibitors.",

keywords = "Acute coronary syndrome (ACS), Coagulation (COAG), Percutaneous coronary intervention (PCI), Thrombosis (THRM)",

author = "Sharma, \{Samin K.\}",

year = "2010",

doi = "10.1002/ccd.22367",

language = "English",

volume = "75",

pages = "S7--S14",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "John Wiley and Sons Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Oral antiplatelet therapy in PCI patients

AU - Sharma, Samin K.

PY - 2010

Y1 - 2010

N2 - The use of percutaneous coronary intervention (PCI) in the treatment of obstructive coronary artery disease has expanded rapidly in the past decade. Despite the extensive technological advancements in the field, pharmacotherapy has remained a cornerstone in the overall treatment strategy. Oral antiplatelet therapy has become an essential component of therapy with acute coronary syndromes and in PCI by improving clinical outcomes. This article reviews the antiplatelet options for patients undergoing PCI, including aspirin, ADP receptor blockers, and glycoprotein IIb/IIIa inhibitors.

AB - The use of percutaneous coronary intervention (PCI) in the treatment of obstructive coronary artery disease has expanded rapidly in the past decade. Despite the extensive technological advancements in the field, pharmacotherapy has remained a cornerstone in the overall treatment strategy. Oral antiplatelet therapy has become an essential component of therapy with acute coronary syndromes and in PCI by improving clinical outcomes. This article reviews the antiplatelet options for patients undergoing PCI, including aspirin, ADP receptor blockers, and glycoprotein IIb/IIIa inhibitors.

KW - Acute coronary syndrome (ACS)

KW - Coagulation (COAG)

KW - Percutaneous coronary intervention (PCI)

KW - Thrombosis (THRM)

UR - https://www.scopus.com/pages/publications/77950449919

U2 - 10.1002/ccd.22367

DO - 10.1002/ccd.22367

M3 - Review article

C2 - 20333709

AN - SCOPUS:77950449919

SN - 1522-1946

VL - 75

SP - S7-S14

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - SUPPL. 1

ER -

Oral antiplatelet therapy in PCI patients

Abstract

Keywords

Access to Document

Fingerprint

Cite this